• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    UL Solutions Announces Pricing of Secondary Public Offering of Class A Common Stock

    12/3/25 11:00:00 PM ET
    $ULS
    Precision Instruments
    Health Care
    Get the next $ULS alert in real time by email

    UL Solutions Inc. (NYSE:ULS) ("UL Solutions") today announced the pricing of its underwritten public offering (the "offering") of 12,500,000 shares of its Class A common stock at a public offering price of $78.00 per share. The offering consists entirely of secondary shares to be sold by UL Standards & Engagement (the "selling stockholder"). The underwriters have a 30-day option to purchase up to an additional 1,875,000 shares of Class A common stock from the selling stockholder at the public offering price, less underwriting discounts and commissions. UL Solutions is not offering any shares of its Class A common stock in the offering and will not receive any proceeds from the sale of the shares. The offering is expected to close on December 5, 2025, subject to customary closing conditions.

    Goldman Sachs & Co. LLC and J.P. Morgan (in alphabetical order) are acting as lead managing bookrunners with BofA Securities acting as a managing bookrunner. Jefferies, UBS Investment Bank and BNP Paribas are acting as additional bookrunners for the offering. Baird, BTIG, Houlihan Lokey, Loop Capital Markets, PNC Capital Markets LLC, Raymond James, Stifel, William Blair, AmeriVet Securities, Bancroft Capital, Cabrera Capital Markets LLC and R. Seelaus & Co., LLC are acting as co-managers for the offering.

    The offering is being made pursuant to a shelf registration statement on Form S-3, including a base prospectus, that was filed by the Company with the Securities and Exchange Commission (the "SEC") and became automatically effective upon filing on August 5, 2025. The offering is being made only by means of a prospectus supplement and the accompanying base prospectus. A preliminary prospectus supplement and the accompanying prospectus relating to and describing the terms of the offering was filed with the SEC by the Company and is available on the SEC's website located at www.sec.gov, and a final prospectus supplement describing the terms of the offering will be filed with the SEC by the Company and will be available on the SEC's website. When available, copies of the final prospectus supplement and the accompanying prospectus relating to the offering may be obtained from: Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, NY 10282, via telephone: (866) 471-2526, via fax: 212-902-9316, or via email: [email protected] and J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or by email at [email protected] and [email protected].

    This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

    Jefferies acted as capital markets advisor to the selling stockholder.

    About UL Solutions

    A global leader in applied safety science, UL Solutions (NYSE:ULS) transforms safety, security and sustainability challenges into opportunities for customers in more than 110 countries. UL Solutions delivers testing, inspection and certification services, together with software products and advisory offerings, that support our customers' product innovation and business growth. The UL Mark serves as a recognized symbol of trust in our customers' products and reflects an unwavering commitment to advancing our safety mission. We help our customers innovate, launch new products and services, navigate global markets and complex supply chains, and grow sustainably and responsibly into the future. Our science is your advantage.

    Cautionary Note Regarding Forward-Looking Statements

    Certain statements in this press release, which are not historical facts, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These include statements regarding the closing of the offering. These statements are neither promises nor guarantees and involve known and unknown risks, uncertainties and other factors that may cause our actual results or performance to differ materially from those expressed or implied by the forward-looking statements made in this press release, including those set forth under "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Part I, Item 2 of UL Solutions' Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, "Risk Factors" in Part I, Item 1A of the Company's Annual Report on Form 10-K for the year ended December 31, 2024, and the risks discussed in UL Solutions' other filings with the SEC, including the registration statement on Form S-3 related to the offering, each of which is accessible on the SEC's website at www.sec.gov. Such forward-looking statements are made only as of the date of this press release. UL Solutions does not undertake or assume any obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting such forward-looking statements, except to the extent required by law.

    Source Code: ULS-IR

    View source version on businesswire.com: https://www.businesswire.com/news/home/20251203339559/en/

    Media:

    Kathy Fieweger

    Senior Vice President and Chief Corporate Communications Officer

    [email protected]

    312-852-5156

    Investors:

    Yijing Brentano

    Vice President, Investor Relations

    [email protected]

    312-895-9873

    Get the next $ULS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ULS

    DatePrice TargetRatingAnalyst
    11/5/2025$84.00Overweight → Neutral
    Analyst
    5/14/2025$71.00Buy → Neutral
    Citigroup
    10/7/2024$60.00Buy
    Citigroup
    7/12/2024$41.00 → $46.00Outperform → Neutral
    Robert W. Baird
    More analyst ratings

    $ULS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: SEC Form 4 filed by EVP & CCO Uggetti Alberto

    4/A - UL Solutions Inc. (0001901440) (Issuer)

    11/28/25 5:14:16 PM ET
    $ULS
    Precision Instruments
    Health Care

    SEC Form 4 filed by Director Shannon James M

    4 - UL Solutions Inc. (0001901440) (Issuer)

    10/6/25 4:45:18 PM ET
    $ULS
    Precision Instruments
    Health Care

    SEC Form 4 filed by Director Susman Sally

    4 - UL Solutions Inc. (0001901440) (Issuer)

    9/10/25 6:15:43 PM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    SEC Filings

    View All

    UL Solutions Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - UL Solutions Inc. (0001901440) (Filer)

    12/5/25 4:05:30 PM ET
    $ULS
    Precision Instruments
    Health Care

    SEC Form 424B7 filed by UL Solutions Inc.

    424B7 - UL Solutions Inc. (0001901440) (Filer)

    12/4/25 9:42:52 PM ET
    $ULS
    Precision Instruments
    Health Care

    SEC Form 424B7 filed by UL Solutions Inc.

    424B7 - UL Solutions Inc. (0001901440) (Filer)

    12/2/25 4:08:03 PM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    UL Solutions Inc. downgraded by Analyst with a new price target

    Analyst downgraded UL Solutions Inc. from Overweight to Neutral and set a new price target of $84.00

    11/5/25 7:29:40 AM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Inc. downgraded by Citigroup with a new price target

    Citigroup downgraded UL Solutions Inc. from Buy to Neutral and set a new price target of $71.00

    5/14/25 8:58:56 AM ET
    $ULS
    Precision Instruments
    Health Care

    Citigroup resumed coverage on UL Solutions Inc. with a new price target

    Citigroup resumed coverage of UL Solutions Inc. with a rating of Buy and set a new price target of $60.00

    10/7/24 8:45:25 AM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CRH, Carvana and Comfort Systems USA Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Dec. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, December 22, to coincide with the quarterly rebalance. The changes ensure that each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space.  Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector Dec 22, 2025  S&P 500 Addition CRH CRH Mat

    12/5/25 5:49:00 PM ET
    $ASIX
    $BAH
    $BWA
    Major Chemicals
    Industrials
    Professional Services
    Consumer Discretionary

    UL Solutions Announces Pricing of Secondary Public Offering of Class A Common Stock

    UL Solutions Inc. (NYSE:ULS) ("UL Solutions") today announced the pricing of its underwritten public offering (the "offering") of 12,500,000 shares of its Class A common stock at a public offering price of $78.00 per share. The offering consists entirely of secondary shares to be sold by UL Standards & Engagement (the "selling stockholder"). The underwriters have a 30-day option to purchase up to an additional 1,875,000 shares of Class A common stock from the selling stockholder at the public offering price, less underwriting discounts and commissions. UL Solutions is not offering any shares of its Class A common stock in the offering and will not receive any proceeds from the sale of the s

    12/3/25 11:00:00 PM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Announces Launch of Proposed Secondary Public Offering of Class A Common Stock

    UL Solutions Inc. (NYSE:ULS) ("UL Solutions") today announced the commencement of an underwritten public offering (the "offering") of 12,500,000 shares of its Class A common stock. The offering consists entirely of secondary shares to be sold by UL Standards & Engagement (the "selling stockholder"). The underwriters will have a 30-day option to purchase up to an additional 1,875,000 shares of Class A common stock from the selling stockholder at the public offering price, less underwriting discounts and commissions. UL Solutions is not offering any shares of its Class A common stock in the proposed offering and will not receive any proceeds from the proposed sale of the shares. Goldman Sach

    12/2/25 4:02:00 PM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    Leadership Updates

    Live Leadership Updates

    View All

    CRH, Carvana and Comfort Systems USA Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Dec. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, December 22, to coincide with the quarterly rebalance. The changes ensure that each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space.  Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector Dec 22, 2025  S&P 500 Addition CRH CRH Mat

    12/5/25 5:49:00 PM ET
    $ASIX
    $BAH
    $BWA
    Major Chemicals
    Industrials
    Professional Services
    Consumer Discretionary

    UL Solutions Breaks Ground on Global Fire Science Center of Excellence in Illinois

    The advanced fire safety testing and R&D facility will be dedicated to identifying, evaluating and mitigating fire risks. UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced the beginning of construction on its state-of-the-art Global Fire Science Center of Excellence, one of the company's largest laboratory investments to date, helping to reduce fire risks globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250826231103/en/UL Solutions has announced the beginning of construction on its state-of-the-art Global Fire Science Center of Excellence, one of the company's largest laboratory i

    8/26/25 5:30:00 PM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Inc. Names New Chief Legal Officer

    UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced it appointed Scott D'Angelo as executive vice president and chief legal officer, effective April 21, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250311928632/en/UL Solutions names Scott D'Angelo as executive vice president and chief legal officer (Photo: Business Wire) D'Angelo's appointment fills a vacant role and he joins the company's executive leadership team, reporting to President and CEO Jennifer Scanlon. D'Angelo will oversee the legal, brand integrity, ethics and compliance functions. He most recently served as vice presiden

    3/11/25 9:15:00 AM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    Financials

    Live finance-specific insights

    View All

    UL Solutions Announces Quarterly Dividend

    UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced that its board of directors has declared a quarterly dividend of $0.13 per share. The dividend will be paid on Dec. 8 to shareholders of record as of the close of business on Nov. 28. About UL Solutions A global leader in applied safety science, UL Solutions (NYSE:ULS) transforms safety, security and sustainability challenges into opportunities for customers in more than 110 countries. UL Solutions delivers testing, inspection and certification services, together with software products and advisory offerings, that support our customers' product innovation and business growth. The UL Mark serves as

    11/11/25 4:45:00 PM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Inc. Reports Strong Third Quarter 2025 Results

    Third Quarter 20251 Strong revenue growth of 7.1% to $783 million, including 6.3% organic growth Net income of $106 million increased 12.8%, Adjusted Net Income of $119 million increased 14.4%. Net income margin of 13.5% increased 60 basis points Diluted earnings per share of $0.49 increased 11.4%, Adjusted Diluted Earnings Per Share of $0.56 increased 14.3% Adjusted EBITDA of $217 million increased 18.6%, Adjusted EBITDA margin of 27.7% expanded 270 basis points Announcing a restructuring initiative to reduce expenses Strengthening full-year financial outlook UL Solutions Inc. (NYSE:ULS), a global safety science leader in independent third-party testing, inspection and certif

    11/4/25 7:00:00 AM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Sets Date for Third Quarter 2025 Results

    UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced it will release financial results for the third quarter 2025 before the market opens on Tuesday, Nov. 4. Management will host a webcast and conference call that same day at 8:30 a.m. EST (7:30 a.m. CST) to review results. Webcast and Conference Call The conference call will be broadcast live over the Internet. Additionally, a slide presentation will accompany the conference call. To listen to the call and view the slides, please visit the Investors section of UL Solutions' website at www.ul.com. For those who are unable to listen to the live broadcast, an audio replay of the conference call will be

    10/21/25 7:00:00 AM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by UL Solutions Inc.

    SC 13G/A - UL Solutions Inc. (0001901440) (Subject)

    11/13/24 12:26:41 PM ET
    $ULS
    Precision Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by UL Solutions Inc.

    SC 13G/A - UL Solutions Inc. (0001901440) (Subject)

    11/12/24 5:49:12 PM ET
    $ULS
    Precision Instruments
    Health Care

    SEC Form SC 13G filed by UL Solutions Inc.

    SC 13G - UL Solutions Inc. (0001901440) (Subject)

    11/12/24 10:34:15 AM ET
    $ULS
    Precision Instruments
    Health Care